VI Multidyscyplinarna Konferencja Nauki o Leku

 on-line journal

Time
 Duration
 Type
 Presenting person
 Title

May 26th, Monday

08:45 00:30:00 Invited oral Teresa Paszkowska-Reymer The Concept of the Central Strategic Program - Innovative Medicines
09:15 00:30:00 Invited oral Jan Lubiński Genetic contribution to all cancers: implications for pharmaceutical treatment
09:45 00:30:00 Invited oral Zbigniew E. Fijałek Unusual application of X-Ray diffraction in drug control – searching for counterfeit and substandard pharmaceuticals
10:15 00:20:00 Oral Krzysztof Brzózka Focus on drug discovery – new opportunities in life science sector in Poland.
10:35 00:20:00 Oral Krystyna Gryz Registration dossier of chemical active substance
11:25 00:20:00 Oral Małgorzata Jarończyk The ligand binding to the serotonin transporter
11:45 00:20:00 Oral Katarzyna A. Kaźmierska Hydrogel coatings and a local drug delivery
12:05 00:20:00 Oral Lech Kozerski Novel medium for monomer proteins structure elucidation. Human insulin structure in water/ acetonitrile solvent. Search for nonamyloidogenic conditions
12:25 00:20:00 Oral Sebastian Kmiecik Protein modeling in silico: providing new targets for a drug design
12:45 00:20:00 Oral Maria Kraj Bortezomib in multiple myeloma: treatment and retreatment. A single center experience
15:00 00:30:00 Invited oral Jan Barciszewski Human brain tumor therapy through interference RNA intervention
15:30 00:30:00 Invited oral Krzysztof L. Krzystyniak Therapeutic monoclonal antibodies in clinical and scientific data*
16:00 00:20:00 Oral Zbigniew J. Kamiński Synthesis and Screening of the Library of the Supramolecular Structures Formed by N-Lipidated Oligopeptides for Selection of Host Active as Artificial Esterase
16:20 00:20:00 Oral Wojciech Łuniewski Synthesis of selected 14C radiolabelled compounds in recent investigations of new analytical method applied in accelerated drug development (EUMAPP).

May 27th, Tuesday

08:30 00:30:00 Invited oral Marek Chmielewski Strategies of the synthesis of oxa- and carba-penams and cephams
09:00 00:30:00 Invited oral Jerzy Ostrowski Integrative genomics - an essential tool for development of molecular medicine
09:30 00:20:00 Oral Maciej Mikina New phosphonate - based strategy for the synthesis of carbocyclic nucleosides: natural Neplanocin A and its unnatural enantiomer.
09:50 00:20:00 Oral Zofia Mazerska Specific metabolism of antitumor agents with cytochrome P-450 isoenzymes
10:10 00:20:00 Oral Krzysztof Kamiński N-Phenylamino derivatives of 3-substituted pyrrolidine-2,5-diones as potential anticonvulsant agents
10:30 00:20:00 Oral Maria M. Kasprzak Cytotoxic and proapoptotic in vitro activity of two novel flavone complexes of ruthenium(II)
11:20 00:20:00 Oral Agata B. Maciejczyk The role of the Office for Medicinal Products, Medical Devices and Biocidal Products in pharmacovigilance activities in Poland
11:40 00:20:00 Oral Aleksandra E. Mościcka-Studzińska Electrically enhanced and controlled drug delivery through buccal mucosa
12:00 00:20:00 Oral Marek T. Konieczny Comparison of traditional and new methods of drug discovery
12:20 00:20:00 Oral Sławomir Jarosz Synthesis of higher carbon sugars. Unexpected rearrangement of higher sugar allylic alcohols
12:40 00:20:00 Oral Alicja Nowaczyk Newest triazole derivative with antifungal activity: a docking study
15:00 00:30:00 Invited oral Sergiusz Markowicz Harnessing stem cells and dendritic cells for novel therapies
15:30 00:30:00 Invited oral Teresa M. Brodniewicz Scope and  requirements   regarding    preclinical   and human clinical trials  of a  new  medicinal product,   including  biotechnology  and biosimilar products.

May 28th, Wednesday
08:30 00:30:00 Invited oral Barbara Nawrot Therapeutic applications of RNAi
09:00 00:30:00 Invited oral Witold Danikiewicz Applications of Mass Spectrometry in the Analysis of Pharmaceuticals
09:30 00:30:00 Invited oral Michał Fedoryński Phase Transfer Catalysis in pharmaceutical industry – where are we?
10:00 00:20:00 Oral Marcin Nowogródzki Polyhydroxylated decalin derivatives – stereoselective approach from simple sugars via allyltin compounds
10:20 00:20:00 Oral Agnieszka Zagórska Tricyclic theophylline derivatives with arylalkylpiperazinyl moiety as CNS agents
10:40 00:20:00 Oral Stanisław Ryng Two examples of very closely related isoxazoles exhibiting opposite immunological activities
11:30 00:30:00 Invited oral Gabriel Wcisło Molecular underpinnings of the targeted therapy for cancer
12:00 00:30:00 Invited oral Tadeusz Pietrucha Overview of pharmaceutical biotechnology sector in Poland
12:30 00:20:00 Oral Piotr T. Tarnowski LC/MS/MS as a tool for profiling metabolites of active substances
12:50 00:20:00 Oral Maria Bretner Anti-glioma activity of selected CK2 protein kinase inhibitors
13:10 00:20:00 Oral Stanisław Boryczka Synthesis and antiproliferative activity in vitro of (4-substituted-2-butynylthio)quinolines
© 1998-2024 pielaszek research, all rights reserved Powered by the Conference Engine